Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 16, 2015 Filed Dec 18, 2015 22:22 UTC SaleCommon Stock 2,000 $114.72 $229,440.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $114.72 (range $114.20 to $115.19).

Read SEC document
December 16, 2015 Filed Dec 18, 2015 22:22 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2015 Filed Dec 11, 2015 13:43 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-084559 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,600

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 09, 2015 Filed Dec 11, 2015 13:43 UTC SaleCommon Stock 700 $122.74 $85,918.00
Disclosure

SEC source: 0001209191-15-084559 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $122.74 (range $122.55 to $122.85).

Read SEC document
December 09, 2015 Filed Dec 11, 2015 13:43 UTC SaleCommon Stock 810 $122.11 $98,909.10
Disclosure

SEC source: 0001209191-15-084559 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,984

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $122.11 (range $121.52 to $122.38).

Read SEC document
December 09, 2015 Filed Dec 11, 2015 13:43 UTC SaleCommon Stock 3,090 $121.07 $374,106.30
Disclosure

SEC source: 0001209191-15-084559 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,794

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $121.07 (range $120.52 to $121.51).

Read SEC document
December 09, 2015 Filed Dec 11, 2015 13:43 UTC SaleCommon Stock 5,800 $120.24 $697,392.00
Disclosure

SEC source: 0001209191-15-084559 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,884

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $120.24 (range $119.52 to $120.51).

Read SEC document
December 09, 2015 Filed Dec 11, 2015 13:43 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-084559 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2015 Filed Dec 8, 2015 21:17 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionStock Option (right to buy) · Derivative 4,531 $0.00 Strike: $53.74 $0.00
Disclosure

SEC source: 0001209191-15-083969 · doc4.xml · derivative · entry 6

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,594

Underlying: Common Stock · 4,531 shares

Expires 2022-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 09/04/2012.

Read SEC document
December 04, 2015 Filed Dec 8, 2015 21:17 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 100 $125.17 $12,517.00
Disclosure

SEC source: 0001209191-15-083969 · doc4.xml · nonDerivative · entry 4

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,464

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

Read SEC document
December 04, 2015 Filed Dec 8, 2015 21:17 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 2,252 $124.36 $280,058.72
Disclosure

SEC source: 0001209191-15-083969 · doc4.xml · nonDerivative · entry 3

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,564

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $124.36 (range $124.11 to $124.93).

Read SEC document
December 04, 2015 Filed Dec 8, 2015 21:17 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 2,179 $123.53 $269,171.87
Disclosure

SEC source: 0001209191-15-083969 · doc4.xml · nonDerivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,816

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $123.53 (range $123.06 to $124.01).

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 04, 2015 Filed Dec 8, 2015 21:17 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionCommon Stock 4,531 $53.74 $243,495.94
Disclosure

SEC source: 0001209191-15-083969 · doc4.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2015 Filed Dec 4, 2015 21:18 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-083534 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,000

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
December 02, 2015 Filed Dec 4, 2015 21:18 UTC SaleCommon Stock 1,500 $132.01 $198,015.00
Disclosure

SEC source: 0001209191-15-083534 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $132.01 (range $131.80 to $132.33).

Read SEC document
December 02, 2015 Filed Dec 4, 2015 21:18 UTC SaleCommon Stock 3,401 $131.36 $446,755.36
Disclosure

SEC source: 0001209191-15-083534 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,784

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $131.36 (range $130.80 to $131.78).

Read SEC document
December 02, 2015 Filed Dec 4, 2015 21:18 UTC SaleCommon Stock 5,499 $130.33 $716,684.67
Disclosure

SEC source: 0001209191-15-083534 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,185

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $130.33 (range $129.80 to $130.77).

Read SEC document
December 02, 2015 Filed Dec 4, 2015 21:18 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-083534 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:04 UTC
Lee YuchunDirector
Exercise / conversionStock Option (right to buy) · Derivative 1,333 $0.00 Strike: $57.27 $0.00
Disclosure

SEC source: 0001209191-15-083422 · doc4.xml · derivative · entry 5

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,667

Underlying: Common Stock · 1,333 shares

Expires 2022-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 09/14/2012.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:04 UTC
Lee YuchunDirector
SaleCommon Stock 100 $131.21 $13,121.00
Disclosure

SEC source: 0001209191-15-083422 · doc4.xml · nonDerivative · entry 4

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:04 UTC
Lee YuchunDirector
SaleCommon Stock 625 $129.97 $81,231.25
Disclosure

SEC source: 0001209191-15-083422 · doc4.xml · nonDerivative · entry 3

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 933

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $129.97 (range $129.64 to $130.60).

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:04 UTC
Lee YuchunDirector
SaleCommon Stock 400 $128.77 $51,508.00
Disclosure

SEC source: 0001209191-15-083422 · doc4.xml · nonDerivative · entry 2

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,558

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $128.77 (range $128.37 to $129.09).

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:04 UTC
Lee YuchunDirector
Exercise / conversionCommon Stock 1,333 $57.27 $76,340.91
Disclosure

SEC source: 0001209191-15-083422 · doc4.xml · nonDerivative · entry 1

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:02 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $72.14 $0.00
Disclosure

SEC source: 0001209191-15-083420 · doc4.xml · derivative · entry 3

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 5,000 shares

Expires 2024-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:02 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
SaleCommon Stock 5,000 $131.00 $655,000.00
Disclosure

SEC source: 0001209191-15-083420 · doc4.xml · nonDerivative · entry 2

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:02 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionCommon Stock 5,000 $72.14 $360,700.00
Disclosure

SEC source: 0001209191-15-083420 · doc4.xml · nonDerivative · entry 1

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:05 UTC Exercise / conversionStock Option (right to buy) · Derivative 22,500 $0.00 Strike: $59.55 $0.00
Disclosure

SEC source: 0001209191-15-083423 · doc4.xml · derivative · entry 6

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,500 shares

Expires 2022-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:05 UTC SaleCommon Stock 100 $131.38 $13,138.00
Disclosure

SEC source: 0001209191-15-083423 · doc4.xml · nonDerivative · entry 5

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,265

F1 · kind: Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:05 UTC SaleCommon Stock 5,400 $130.68 $705,672.00
Disclosure

SEC source: 0001209191-15-083423 · doc4.xml · nonDerivative · entry 4

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,365

F1 · kind: Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.

F3 · price: Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $130.68 (range $130.26 to $131.25).

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:05 UTC SaleCommon Stock 10,711 $129.77 $1,389,966.47
Disclosure

SEC source: 0001209191-15-083423 · doc4.xml · nonDerivative · entry 3

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,765

F1 · kind: Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.

F3 · price: Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $129.77 (range $129.25 to $130.24).

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:05 UTC SaleCommon Stock 6,289 $128.78 $809,897.42
Disclosure

SEC source: 0001209191-15-083423 · doc4.xml · nonDerivative · entry 2

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,476

F1 · kind: Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $128.78 (range $128.25 to $129.23).

F3 · price: Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 01, 2015 Filed Dec 4, 2015 02:05 UTC Exercise / conversionCommon Stock 22,500 $59.55 $1,339,875.00
Disclosure

SEC source: 0001209191-15-083423 · doc4.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 23, 2015 Filed Nov 25, 2015 15:26 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-082141 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,400

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested.

Read SEC document
November 23, 2015 Filed Nov 25, 2015 15:26 UTC SaleCommon Stock 200 $133.88 $26,776.00
Disclosure

SEC source: 0001209191-15-082141 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

Read SEC document
November 23, 2015 Filed Nov 25, 2015 15:26 UTC SaleCommon Stock 2,000 $132.81 $265,620.00
Disclosure

SEC source: 0001209191-15-082141 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $132.81 (range $132.43 to $133.11).

Read SEC document
November 23, 2015 Filed Nov 25, 2015 15:26 UTC SaleCommon Stock 8,200 $131.98 $1,082,236.00
Disclosure

SEC source: 0001209191-15-082141 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $131.98 (range $131.43 to $132.41).

Read SEC document
November 23, 2015 Filed Nov 25, 2015 15:26 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-082141 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 19, 2015 Filed Nov 23, 2015 20:12 UTC GiftCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-15-081749 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · shares: Represents a gift made to a charitable foundation.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:06 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $63.14 $0.00
Disclosure

SEC source: 0001209191-15-081510 · doc4.xml · derivative · entry 5

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2022-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 05/24/2012.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:06 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $72.14 $0.00
Disclosure

SEC source: 0001209191-15-081510 · doc4.xml · derivative · entry 4

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 7,500 shares

Expires 2024-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:06 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
SaleCommon Stock 15,000 $130.00 $1,950,000.00
Disclosure

SEC source: 0001209191-15-081510 · doc4.xml · nonDerivative · entry 3

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:06 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionCommon Stock 7,500 $63.14 $473,550.00
Disclosure

SEC source: 0001209191-15-081510 · doc4.xml · nonDerivative · entry 2

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:06 UTC
ALTSHULER DAVIDEVP, Global Research and CSO
Exercise / conversionCommon Stock 7,500 $72.14 $541,050.00
Disclosure

SEC source: 0001209191-15-081510 · doc4.xml · nonDerivative · entry 1

ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · derivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,800

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC SaleCommon Stock 400 $133.03 $53,212.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $133.03 (range $132.96 to $133.07).

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC SaleCommon Stock 3,300 $132.44 $437,052.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $132.44 (range $131.95 to $132.89).

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC SaleCommon Stock 3,100 $131.55 $407,805.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,984

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $131.55 (range $130.94 to $131.89).

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC SaleCommon Stock 800 $130.25 $104,200.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,084

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $130.25 (range $129.93 to $130.83).

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC SaleCommon Stock 2,800 $128.96 $361,088.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,884

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $128.96 (range $128.71 to $129.52).

Read SEC document
November 18, 2015 Filed Nov 20, 2015 21:08 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-081517 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.